Daily Dose - Apr 24th, 2026
Daily Dose |
View online
April 24, 2026
China poised to eclipse US innovators with surge in global licensing
Chinese innovation continues in some of the most technically demanding modalities, including antibody-drug conjugates and multi-specific antibodies.
Read More
WuXi Biologics gets South Korean GMP certification for bispecific antibody manufacturing
The certification enables end-to-end commercial manufacturing across drug substance, fill-finish, and packaging for complex biologics targeting oncology indications.
Read More
CordenPharma site passes Brazil’s ANVISA, South Korea’s MFDS GMP inspections
The dual regulatory reviews reported zero observations for the CDMO’s highly potent drug manufacturing facility in Plankstadt, Germany.
Read More